Filing metadata

Accession number
0001567619-22-014200
Form type
Form 3
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Jul 19, 2022
Reporting period
Jul 18, 2022
Description
Initial ownership

Explore SEC Filings Hub